tiprankstipranks
Trending News
More News >
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
Advertisement

Eterna Therapeutics (ERNA) Technical Analysis

Compare
265 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Eterna Therapeutics’s (ERNA) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Eterna Therapeutics is a Sell.
Eterna Therapeutics’s (ERNA) 20-Day exponential moving average is 1.77, while Eterna Therapeutics’s (ERNA) share price is $1.62, making it a Sell.
Eterna Therapeutics’s (ERNA) 50-Day exponential moving average is 2.10, while Eterna Therapeutics’s (ERNA) share price is $1.62, making it a Sell.

Eterna Therapeutics (ERNA) Pivot Points

Aug 15, 2025, 08:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.54
1.58
1.61
1.65
1.68
1.72
1.75
Fibonacci
1.58
1.61
1.63
1.65
1.68
1.70
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Eterna Therapeutics (ERNA) Moving Averages

Aug 15, 2025, 08:59 PM
Period
Simple
Exponential
MA5
1.65Sell
1.64Sell
MA10
1.64Sell
1.68Sell
MA20
1.79Sell
1.77Sell
MA50
2.03Sell
2.10Sell
MA100
2.57Sell
3.11Sell
MA200
4.76Sell
6.42Sell
Eterna Therapeutics’s (ERNA) 10-Day exponential moving average is 1.68, while Eterna Therapeutics’s (ERNA) share price is $1.62, making it a Sell.
Eterna Therapeutics’s (ERNA) 100-Day exponential moving average is 3.11, while Eterna Therapeutics’s (ERNA) share price is $1.62, making it a Sell.
Eterna Therapeutics’s (ERNA) stock price is $1.62 and Eterna Therapeutics’s (ERNA) 50-day simple moving average is 2.03, creating a Sell signal.
Eterna Therapeutics’s (ERNA) stock price is $1.62 and Eterna Therapeutics’s (ERNA) 100-day simple moving average is 2.57, creating a Sell signal.
Eterna Therapeutics’s (ERNA) stock price is $1.62 and Eterna Therapeutics’s (ERNA) 200-day simple moving average is 4.76, creating a Sell signal.

Eterna Therapeutics (ERNA) Technical Indicators

Aug 15, 2025, 08:59 PM
Name
Value
Implied Action
RSI (14)
38.52
Neutral
STOCH (9,6)
52.61
Neutral
STOCHRSI (14)
18.26
Buy
MACD (12,26)
-0.13
Sell
ADX (14)
15.13
Buy
Williams %R
-77.74
Buy
CCI (14)
-72.64
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
47.14
Neutral
ROC
-16.92
Sell
Eterna Therapeutics’s (ERNA) Relative Strength Index (RSI) is 38.52, creating a Neutral signal.
Eterna Therapeutics’s (ERNA) Trend Strength Indicator (ADX) is 15.13, creating a Buy signal.
Eterna Therapeutics’s (ERNA) Commodity Channel Index (CCI) is -72.64, creating a Neutral signal.
Eterna Therapeutics’s (ERNA) Price Rate of Change (ROC) is -16.92, creating a Sell signal.

FAQ

Is ERNA a Buy, Hold, or Sell?
Based on ERNA’s technical indicators, ERNA is a Strong Sell.
    What is ERNA’s RSI (14)?
    ERNA’s RSI (14) is 38.52, which suggests ERNA is a Neutral.
      What is ERNA’s MACD?
      ERNA’s MACD is -0.13, which suggests ERNA is a Sell.
        What is ERNA’s 5-day moving average?
        ERNA’s 5-day moving average is 1.65, which suggests ERNA is a Sell.
          What is ERNA’s 20-day moving average?
          ERNA 20-day moving average is 1.79, which suggests ERNA is a Sell.
            What is ERNA’s 50-day moving average?
            ERNA’s 50-day moving average is 2.03, which suggests ERNA is a Sell.
              What is ERNA’s 200-day moving average?
              ERNA’s 200-day moving average is 4.76, which suggests ERNA is a Sell.
                What is ERNA’s Williams % R (14)?
                ERNA’s Williams % R (14) is -77.74, which suggests ERNA is a Buy.
                  What is ERNA’s CCI (14)?
                  ERNA’s CCI (14) is -72.64, which suggests ERNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis